Increased activation of both NFκB and MAPK signaling pathways have been implicated in the pathogenesis of COPD and asthma, with NFκB upregulation further associated with steroid insensitivity [51], but the potential contribution of bacterial infection to this pathway is still poorly understood. Here, NFKB1 is linked to bacterial infectious disease.